These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11051252)

  • 1. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene.
    Navari JR; Roland PY; Keh P; Salvesen HB; Akslen LA; Iversen OE; Das S; Kothari R; Howey S; Phillips B
    Clin Cancer Res; 2000 Oct; 6(10):4026-32. PubMed ID: 11051252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
    Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
    Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
    Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
    Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
    Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
    Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
    Lapidus RG; Nass SJ; Butash KA; Parl FF; Weitzman SA; Graff JG; Herman JG; Davidson NE
    Cancer Res; 1998 Jun; 58(12):2515-9. PubMed ID: 9635570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
    Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
    Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer.
    Sasaki M; Kotcherguina L; Dharia A; Fujimoto S; Dahiya R
    Cancer Res; 2001 Apr; 61(8):3262-6. PubMed ID: 11309276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
    Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation.
    Asada H; Yamagata Y; Taketani T; Matsuoka A; Tamura H; Hattori N; Ohgane J; Hattori N; Shiota K; Sugino N
    Mol Hum Reprod; 2008 Sep; 14(9):539-45. PubMed ID: 18701604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of estrogen receptor beta mRNA in endometrial carcinoma and its significance].
    Wen H
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):108-10. PubMed ID: 11783346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
    Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
    Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
    Yang X; Ferguson AT; Nass SJ; Phillips DL; Butash KA; Wang SM; Herman JG; Davidson NE
    Cancer Res; 2000 Dec; 60(24):6890-4. PubMed ID: 11156387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
    Taylor AH; al-Azzawi F; Pringle JH; Bell SC
    Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylation in carcinoid and pancreatic endocrine tumors.
    Chan AO; Kim SG; Bedeir A; Issa JP; Hamilton SR; Rashid A
    Oncogene; 2003 Feb; 22(6):924-34. PubMed ID: 12584572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.